BAM66435 Vandetanib
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                    
structure C22H24BrFN4O2
443913-73-3
98+%
MFCD07772346
BAM66435 Zactima
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                    
structure C22H24BrFN4O2
443913-73-3
98+%
MFCD07772346
BAM66435 ZD6474
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                    
structure C22H24BrFN4O2
443913-73-3
98+%
MFCD07772346
BAM66722 NBI 34041
NBI 34041 is a High-affinity CRF1 receptor antagonist Quantity Price 10 mg 70.00                            
structure C22 H26 Cl2 N4
268545-87-5
95%
MFCD18782661
BAM66466 Saracatinib (AZD0530)
Saracatinib (AZD0530) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively. Quantity Price 10 mg 60.00 50 mg 188.00 100 mg 336.00 200 mg $495.00                
structure C27H32ClN5O5
 
98+%
MFCD09832698
[1/6]